Novo Offers $199 Wegovy Special as Cheap Obesity Drugs Become Harder to Get

Wegovy goes on sale after off-ramp for copycats ends

Novo is offering a one-month sale on Wegovy, and its partner telehealth platforms are offering creative ways to squeeze in a margin for themselves....

Novo Offers $199 Wegovy Special as Cheap Obesity Drugs Become Harder to Get

Novo Nordisk A/S is selling its blockbuster weight-loss drug Wegovy to new patients at $199 for the first month as easy access to cheaper copycats comes to an end.

Novo Nordisk has started a bit of a price war in the US market, where the price of Wegovy has plummeted.

Evernorth Benefit Option Will Cap Wegovy, Zepbound Monthly Cost at $200

The new program aims to reduce costs for patients, with savings estimated at as much as $3600 per year.

Evernorth to Cap Out-of-Pocket Cost for Wegovy and Zepbound at $200

Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.

Wegovy and Zepbound costs capped at $200 in new Evernorth programme - Pharmaceutical Technology

The lower out-of-pocket costs come at a time of governmental scrutiny on prescription drug prices in the US.